Drug company Wyeth pays big for causing breast cancer

Wyeth officials say their hormone replacement therapy Prempro is not the cause of one Ohio woman's breast cancer. But two jury decisions prove otherwise.

The first jury, in October, awarded Jennie Nelson and her husband $1.5 million in compensatory damages, validating Nelson's claim that her breast cancer -- resulting in a double mastectomy, chemotherapy, and radiation -- was caused by the Prempro she took for six years. When this verdict was ... Full Story »

Posted by Kaizar Campwala
Tags Help
Subjects: Health, Business, Politics, U.S.
Topics: Cancer, Health Care
Member Tags: Wyeth, Premarin, Prempro
Editorial Help
Posted by: Posted by Kaizar Campwala - Feb 21, 2007 - 9:23 AM PST
Edit Lock: This story can be edited
Edited by: Kaizar Campwala - Feb 21, 2007 - 9:23 AM PST

To:


Separate email addresses with commas.
25 recipients max.

Note:

Reviews

Show All | Notes | Comments | Quotes | Links
Member_photo_thumb
3.6
by Marty Heyman - Feb. 22, 2007

This is a potentially important story for patients taking this or other drugs. It reports trial results and awards and the opinions of both sides on the merits of the claims and case. It is a shame the blog author didn't have a quote from the pharmaceutical compay but he does try to provide some balance lacking that. Note that the heavily updated Bloomberg story (linked) manages to get some quotes from the company and a supporting spokesperson.

See Full Review » (10 answers)
Silhouette_sml
2.9
by Joe Pallas - Feb. 26, 2007

This story is written in a journalistic style, but it is very biased reporting. Beginning with the second sentence, the story abandons objectivity by suggesting that a verdict in a civil trial is "proof." Also, the story quotes the plaintiff's lawyer directly, but has no direct quotes from anyone representing Wyeth (although it does attribute statements to Wyeth).

See Full Review » (6 answers)
Member_photo_thumb
3.0
by Kaizar Campwala - Feb. 21, 2007
See Full Review » (1 answer)
Silhouette_sml
4.7
by Bonnie Britt - Feb. 21, 2007

This is an important story and it is not obvious why it did not receive more attention except to observe that some mainstream publications play follow the leader in promoting fluff rather than stories that maybe critical of their advertisers. While the Cancer Blog got it right, I would have preferred to see links to news stories confirming the trial's outcome in the Cancer Blog report. The Cancer Blog, however, correctly reported the outcome whereas law.com got it inexplicably wrong ... More »

See Full Review » (12 answers)

Comments on this story Help (BETA)

NT Rating | My Rating

Ratings

3.6

Good
from 4 reviews (40% confidence)
Quality
3.7
Facts
4.0
Fairness
3.3
Information
4.0
Sourcing
3.3
Style
4.5
Accuracy
5.0
Balance
4.0
Context
3.3
Popularity
3.6
Recommendation
3.8
# Reviews
2.0
# Views
2.6
# Likes
1.0
# Emails
1.0
More
How our ratings work »